Detection of Experimental Hepatic Tumors Using Long Circulating Superparamagnetic Particles
- 1 January 2001
- journal article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 36 (1) , 15-21
- https://doi.org/10.1097/00004424-200101000-00003
Abstract
To evaluate the potential of an iron oxide-based MR contrast agent for the detection and delineation of experimental liver tumors during the early vascular phase of the compoundKeywords
This publication has 12 references indexed in Scilit:
- Hepatic MRI with SPIO: detection and characterization of focal liver lesionsEuropean Radiology, 1998
- LIVER-SPECIFIC MR IMAGING CONTRAST AGENTSRadiologic Clinics of North America, 1998
- Intratumoral Vascularity of Experimentally Induced VX2 CarcinomaInvestigative Radiology, 1998
- Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particlesMagnetic Resonance Imaging, 1997
- MRI quantitative myocardial perfusion with compartmental analysis: A rest and stress studyMagnetic Resonance in Medicine, 1997
- Gray-Scale Liver Enhancement in VX2 Tumor-Bearing Rabbits Using BR14, a New Ultrasonographic Contrast AgentInvestigative Radiology, 1997
- Enhancement of Liver Hemangiomas on T1-Weighted MR SE Images by Superparamagnetic Iron Oxide ParticlesJournal of Computer Assisted Tomography, 1994
- Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxideMagnetic Resonance Imaging, 1993
- Age Related Changes in Tumor VascularityActa Radiologica. Diagnosis, 1984
- A TRANSPLANTABLE RABBIT CARCINOMA ORIGINATING IN A VIRUS-INDUCED PAPILLOMA AND CONTAINING THE VIRUS IN MASKED OR ALTERED FORMThe Journal of Experimental Medicine, 1940